Abstract 2737
Background
Well-differentiated liposarcomas (WDLPS) can be difficult to distinguish from lipomas. Currently, this distinction is made by testing for MDM2-amplification, which requires a biopsy. The aim of this study was to non-invasively predict the MDM2-amplification status using radiomics, i.e. a combination of quantitative imaging features and machine learning techniques, thereby differentiating between lipomas and WDLPS.
Methods
Patients with a lipoma or WDLPS, a known MDM2-amplification status and a pre-treatment T1-weighted MRI scan who were referred to or diagnosed at the Erasmus MC from 2009-2018 were included. When available, other sequences, e.g. T2-weighted (fat-saturated) MRI, were included in the radiomics analysis. Imaging features describing intensity, shape, orientation and texture were extracted from the tumor segmentations; age, gender, tumor depth and tumor localization were added as semantic features. Classification was performed using an ensemble of various machine learning approaches. Evaluation was performed through 100x random-split cross-validation.
Results
We included 116 patients: 58 patients with lipoma and 58 patients with WDLPS. The dataset originated from 41 MRI-scanners, resulting in large heterogeneity in imaging hardware and acquisition protocols. The best performing radiomics approach to differentiate between WDLPS and lipomas, based on T1-weighted imaging only, resulted in a mean [95% confidence interval] AUC of 0.75 [0.65-0.86], accuracy of 0.68 [0.59-0.77], sensitivity of 0.63 [0.48-0.78] and specificity of 0.73 [0.59-0.87]. A model based on the combination of imaging and semantic featured showed only a minor and non-significant improvement in performance.
Conclusions
There is a significant relationship between a radiomics signature, consisting of a combination of quantitative MRI features, and the MDM2-amplification status. Although further optimization and validation is needed for the transition to clinical practice, radiomics has appeared to be a promising, non-invasive approach for the classification of WDLPS and lipomas.
Clinical trial identification
Editorial acknowledgement
M.Vos and M.P.A. Starmans contributed equally to this study.
Legal entity responsible for the study
The authors.
Funding
Stichting Coolsingel, Netherlands Organisation for Scientific Research, Dutch Cancer Society.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
592 - Effects of novel targeted anticancer drugs on cytotoxicity, apoptosis, angiogenesis, EMT, drug resistance and autophagic mechanism
Presenter: Seyma Aydinlik
Session: Poster Display session 1
Resources:
Abstract
3235 - Delineating the mechanisms of alpha 1-3 fucosyltransferase FUT11 in ovarian cancer
Presenter: Qi Chen
Session: Poster Display session 1
Resources:
Abstract
3577 - The tyrosine kinase inhibitor Dasatinib blocks tumor growth, invasion and recurrence potential by interrupting the communication between cancer cells and their surrounding microenvironment in triple negative breast cancer
Presenter: Miriam Nuncia-Cantarero
Session: Poster Display session 1
Resources:
Abstract
4808 - NORE1A induces a feedback termination of TNF signaling by antagonizing TNFR1 through ITCH-mediated destruction complex
Presenter: Jieun Ahn
Session: Poster Display session 1
Resources:
Abstract
1294 - Hsp90 inhibitors enhance the antitumoral effect of osimertinib and overcome osimertinib resistance in non-small-cell cell lung cancer cell models
Presenter: Jordi Codony-Servat
Session: Poster Display session 1
Resources:
Abstract
1559 - Expression of IL-17RA promotes cancer stem-like properties of colorectal cancer cells by Stat3 activation
Presenter: Chih-Yung Yang
Session: Poster Display session 1
Resources:
Abstract
1615 - Adaption of Pancreatic Cancer Cells to AKT1 Inhibition Induces the Acquisition of Cancer Stem-Cell Like Phenotype Through Upregulation of Mitochondrial Functions
Presenter: Hugo Arasanz
Session: Poster Display session 1
Resources:
Abstract
4793 - Bub3 is phosphorylated by the Ataxia-Telangiectasia Mutated Kinase in mitosis and required for activation of the mitotic spindle checkpoint in Breast Cancer
Presenter: Mingming Xiao
Session: Poster Display session 1
Resources:
Abstract
1448 - The regulation of INK4 locus by long non-coding RNAs
Presenter: Yojiro Kotake
Session: Poster Display session 1
Resources:
Abstract
1858 - Vascular Endothelial Growth Factor in Colorectal Cancer Pathology, Survival and Treatment
Presenter: Liz Baker
Session: Poster Display session 1
Resources:
Abstract